Search

Your search keyword '"Ugolini C"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Ugolini C" Remove constraint Author: "Ugolini C" Topic proto-oncogene proteins b-raf Remove constraint Topic: proto-oncogene proteins b-raf
17 results on '"Ugolini C"'

Search Results

1. Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations.

2. Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.

3. Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.

4. Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.

5. BRAF K601E Mutation in a Follicular Thyroid Adenoma: A Case Report.

6. Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.

7. Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.

8. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.

9. BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features.

10. Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma.

11. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.

12. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

13. The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma.

14. Presence of BRAF V600E in very early stages of papillary thyroid carcinoma.

15. Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma

16. The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma

17. ASSOCIATION OF BRAF V600E MUTATION WITH POOR CLINICOPATHOLOGICAL OUTCOMES IN 500 CONSECUTIVE CASES OF PAPILLARY THYROID CARCINOMA

Catalog

Books, media, physical & digital resources